Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject

Published:2018-07-31 Issue:12 Volume:32 Page:1727-1729
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Rossotti Roberto,Maggioni Marco,Merli Marco,Orcese Carloandrea,Iavarone Massimo,Puoti Massimo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference12 articles.

1. Risk factors for severe hepatic injury following the introduction of HAART;Núñez;J Acquir Immune Defic Syndr,2001

2. Antiretroviral drugs and liver injury;Soriano;AIDS,2008

3. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis;Alvarez;J Hepatol,1999

4. Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naïve adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study;Clotet;Lancet,2014

5. Dolutegravir plus abacavir–lamivudine for the treatment of HIV-1 infection;Walmsley;N Engl J Med,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved;Cells;2021-07-04

2. Abacavir/dolutegravir/lamivudine;Reactions Weekly;2018-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP